<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>141(4)</volume><submitter>Bothun ED</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>Glaucoma can develop following cataract removal in children.&lt;h4>Objective&lt;/h4>To assess the cumulative incidence of glaucoma-related adverse events (defined as glaucoma or glaucoma suspect) and factors associated with risk of these adverse events in the first 5 years after lensectomy prior to 13 years of age.&lt;h4>Design, setting, and participants&lt;/h4>This cohort study used longitudinal registry data collected at enrollment and annually for 5 years from 45 institutional and 16 community sites. Participants were children aged 12 years or younger with at least 1 office visit after lensectomy from June 2012 to July 2015. Data were analyzed from February through December 2022.&lt;h4>Exposures&lt;/h4>Usual clinical care after lensectomy.&lt;h4>Main outcomes and measures&lt;/h4>The main outcomes were cumulative incidence of glaucoma-related adverse events and baseline factors associated with risk of these adverse events.&lt;h4>Results&lt;/h4>The study included 810 children (1049 eyes); 443 eyes of 321 children (55% female; mean [SD] age, 0.89 [1.97] years) were aphakic after lensectomy, and 606 eyes of 489 children (53% male; mean [SD] age, 5.65 [3.32] years) were pseudophakic. The 5-year cumulative incidence of glaucoma-related adverse events was 29% (95% CI, 25%-34%) in 443 eyes with aphakia and 7% (95% CI, 5%-9%) in 606 eyes with pseudophakia; 7% (95% CI, 5%-10%) of aphakic eyes and 3% (95% CI, 2%-5%) of pseudophakic eyes were diagnosed as glaucoma suspect. Among aphakic eyes, a higher risk for glaucoma-related adverse events was associated with 4 of 8 factors, including age less than 3 months (vs ≥3 months: adjusted hazard ratio [aHR], 2.88; 99% CI, 1.57-5.23), abnormal anterior segment (vs normal: aHR, 2.88; 99% CI, 1.56-5.30), intraoperative complications at time of lensectomy (vs none; aHR, 2.25; 99% CI, 1.04-4.87), and bilaterality (vs unilaterality: aHR, 1.88; 99% CI, 1.02-3.48). Neither of the 2 factors evaluated for pseudophakic eyes, laterality and anterior vitrectomy, were associated with risk of glaucoma-related adverse events.&lt;h4>Conclusions and relevance&lt;/h4>In this cohort study, glaucoma-related adverse events were common after cataract surgery in children; age less than 3 months at surgery was associated with elevated risk of the adverse events in aphakic eyes. Children with pseudophakia, who were older at surgery, less frequently developed a glaucoma-related adverse event within 5 years of lensectomy. The findings suggest that ongoing monitoring for the development of glaucoma is needed after lensectomy at any age.</pubmed_abstract><journal>JAMA ophthalmology</journal><pagination>324-331</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9936384</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Incidence of Glaucoma-Related Adverse Events in the First 5 Years After Pediatric Lensectomy.</pubmed_title><pmcid>PMC9936384</pmcid><pubmed_authors>Conner CL</pubmed_authors><pubmed_authors>Suh D</pubmed_authors><pubmed_authors>Herlihy EP</pubmed_authors><pubmed_authors>Sanders EN</pubmed_authors><pubmed_authors>Yanovitch TL</pubmed_authors><pubmed_authors>Kieser T</pubmed_authors><pubmed_authors>Lingua R</pubmed_authors><pubmed_authors>Taylor K</pubmed_authors><pubmed_authors>Colburn J</pubmed_authors><pubmed_authors>Grijalva J</pubmed_authors><pubmed_authors>Kraus CL</pubmed_authors><pubmed_authors>Astle WF</pubmed_authors><pubmed_authors>Fisher A</pubmed_authors><pubmed_authors>Haider KM</pubmed_authors><pubmed_authors>Ralay-Ranaivo H</pubmed_authors><pubmed_authors>Christiansen SP</pubmed_authors><pubmed_authors>Poff SW</pubmed_authors><pubmed_authors>Trumler AA</pubmed_authors><pubmed_authors>Hoepner JE</pubmed_authors><pubmed_authors>Bothun ED</pubmed_authors><pubmed_authors>Neiman AE</pubmed_authors><pubmed_authors>Prakalapakorn S</pubmed_authors><pubmed_authors>Phelps DL</pubmed_authors><pubmed_authors>Shea C</pubmed_authors><pubmed_authors>Hashmi T</pubmed_authors><pubmed_authors>Burkman D</pubmed_authors><pubmed_authors>Whitehead GF</pubmed_authors><pubmed_authors>Yoon H</pubmed_authors><pubmed_authors>Hug D</pubmed_authors><pubmed_authors>Rosado J</pubmed_authors><pubmed_authors>Hatt SR</pubmed_authors><pubmed_authors>Golden R</pubmed_authors><pubmed_authors>Salvin JH</pubmed_authors><pubmed_authors>Belanger C</pubmed_authors><pubmed_authors>Manny RE</pubmed_authors><pubmed_authors>Dean TW</pubmed_authors><pubmed_authors>Clausius DA</pubmed_authors><pubmed_authors>Henderson RJ</pubmed_authors><pubmed_authors>Klein S</pubmed_authors><pubmed_authors>Whitfill CR</pubmed_authors><pubmed_authors>Hemberger JC</pubmed_authors><pubmed_authors>Strominger MB</pubmed_authors><pubmed_authors>Welnick N</pubmed_authors><pubmed_authors>Enyedi LB</pubmed_authors><pubmed_authors>Colon B</pubmed_authors><pubmed_authors>Van Iderstine SC</pubmed_authors><pubmed_authors>Austin DS</pubmed_authors><pubmed_authors>Repka MX</pubmed_authors><pubmed_authors>de Alba Campomanes AG</pubmed_authors><pubmed_authors>Cotter SA</pubmed_authors><pubmed_authors>Hammond BP</pubmed_authors><pubmed_authors>Baker JD</pubmed_authors><pubmed_authors>Cruz OA</pubmed_authors><pubmed_authors>Schloff S</pubmed_authors><pubmed_authors>Ventura G</pubmed_authors><pubmed_authors>Peters RJ</pubmed_authors><pubmed_authors>Shan X</pubmed_authors><pubmed_authors>Birch EE</pubmed_authors><pubmed_authors>Chen V</pubmed_authors><pubmed_authors>Davis B</pubmed_authors><pubmed_authors>Kemmer JD</pubmed_authors><pubmed_authors>Traboulsi E</pubmed_authors><pubmed_authors>Hilbrands J</pubmed_authors><pubmed_authors>Kraker RT</pubmed_authors><pubmed_authors>Sauberan DP</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Wilson LB</pubmed_authors><pubmed_authors>Leske DA</pubmed_authors><pubmed_authors>Lenhart P</pubmed_authors><pubmed_authors>Robinson JL</pubmed_authors><pubmed_authors>Rahmani B</pubmed_authors><pubmed_authors>Fimbel BP</pubmed_authors><pubmed_authors>Davis PL</pubmed_authors><pubmed_authors>Hamidullah A</pubmed_authors><pubmed_authors>Peterson CH</pubmed_authors><pubmed_authors>Jordan C</pubmed_authors><pubmed_authors>McConnell KH</pubmed_authors><pubmed_authors>Holmes JM</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Melia BM</pubmed_authors><pubmed_authors>Baran F</pubmed_authors><pubmed_authors>Areaux R</pubmed_authors><pubmed_authors>Sala NA</pubmed_authors><pubmed_authors>Yen KG</pubmed_authors><pubmed_authors>Silver JL</pubmed_authors><pubmed_authors>Khammar AJ</pubmed_authors><pubmed_authors>Tamkins SM</pubmed_authors><pubmed_authors>Larson SA</pubmed_authors><pubmed_authors>Robertson E</pubmed_authors><pubmed_authors>Yang MB</pubmed_authors><pubmed_authors>Pediatric Eye Disease Investigator Group</pubmed_authors><pubmed_authors>Stahl ED</pubmed_authors><pubmed_authors>Mets-Halgrimson R</pubmed_authors><pubmed_authors>Pineles SL</pubmed_authors><pubmed_authors>Melese E</pubmed_authors><pubmed_authors>Gandhi N</pubmed_authors><pubmed_authors>Guo S</pubmed_authors><pubmed_authors>Mendoza MN</pubmed_authors><pubmed_authors>Park HS</pubmed_authors><pubmed_authors>Frohwein JJ</pubmed_authors><pubmed_authors>Dent RJ</pubmed_authors><pubmed_authors>O'Hara M</pubmed_authors><pubmed_authors>Tychsen L</pubmed_authors><pubmed_authors>LaRoche GR</pubmed_authors><pubmed_authors>Jin J</pubmed_authors><pubmed_authors>Longmuir S</pubmed_authors><pubmed_authors>Quebbemann M</pubmed_authors><pubmed_authors>Oravec SA</pubmed_authors><pubmed_authors>Rudaitis I</pubmed_authors><pubmed_authors>Droste PJ</pubmed_authors><pubmed_authors>Beck RW</pubmed_authors><pubmed_authors>Superstein R</pubmed_authors><pubmed_authors>Benson SL</pubmed_authors><pubmed_authors>Peterson E</pubmed_authors><pubmed_authors>Hercinovic A</pubmed_authors><pubmed_authors>Chamberlain C</pubmed_authors><pubmed_authors>Stutz KM</pubmed_authors><pubmed_authors>Everett DF</pubmed_authors><pubmed_authors>Stillman SM</pubmed_authors><pubmed_authors>Sala AM</pubmed_authors><pubmed_authors>Ortiz G</pubmed_authors><pubmed_authors>Bradfield YS</pubmed_authors><pubmed_authors>Orge F</pubmed_authors><pubmed_authors>Foster NC</pubmed_authors><pubmed_authors>Mellott M</pubmed_authors><pubmed_authors>McOwen DC</pubmed_authors><pubmed_authors>Clarke MP</pubmed_authors><pubmed_authors>Holleschau AM</pubmed_authors><pubmed_authors>Powell C</pubmed_authors><pubmed_authors>McCourt EA</pubmed_authors><pubmed_authors>Brower J</pubmed_authors><pubmed_authors>Wheeler AM</pubmed_authors><pubmed_authors>Brickman-Kelleher J</pubmed_authors><pubmed_authors>Ramsey JE</pubmed_authors><pubmed_authors>Ruark ST</pubmed_authors><pubmed_authors>Azar NF</pubmed_authors><pubmed_authors>Jones SK</pubmed_authors><pubmed_authors>Kong L</pubmed_authors><pubmed_authors>Diener-West M</pubmed_authors><pubmed_authors>Lee KA</pubmed_authors><pubmed_authors>Thibeault M</pubmed_authors><pubmed_authors>Verderber LC</pubmed_authors><pubmed_authors>Anninger W</pubmed_authors><pubmed_authors>Smith JM</pubmed_authors><pubmed_authors>Chang T</pubmed_authors><pubmed_authors>Gearinger MD</pubmed_authors><pubmed_authors>Salchow DJ</pubmed_authors><pubmed_authors>Schweinler BR</pubmed_authors><pubmed_authors>Hendricks DH</pubmed_authors><pubmed_authors>Lunsford K</pubmed_authors><pubmed_authors>Wernimont SM</pubmed_authors><pubmed_authors>Baker J</pubmed_authors><pubmed_authors>Donahue Q</pubmed_authors><pubmed_authors>Lowery RS</pubmed_authors><pubmed_authors>Ticho BH</pubmed_authors><pubmed_authors>Anderson JS</pubmed_authors><pubmed_authors>Wallace DK</pubmed_authors><pubmed_authors>Kurup SP</pubmed_authors><pubmed_authors>Woodard VC</pubmed_authors><pubmed_authors>Brooks D</pubmed_authors><pubmed_authors>Singh J</pubmed_authors><pubmed_authors>Erzurum SA</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Summers AI</pubmed_authors><pubmed_authors>Weise KK</pubmed_authors><pubmed_authors>Wu R</pubmed_authors><pubmed_authors>Whitaker ME</pubmed_authors><pubmed_authors>Bernardo MJ</pubmed_authors><pubmed_authors>Therriault M</pubmed_authors><pubmed_authors>Gray ME</pubmed_authors><pubmed_authors>Gladstone A</pubmed_authors><pubmed_authors>Madigan WP</pubmed_authors><pubmed_authors>Sutherland DR</pubmed_authors><pubmed_authors>Karp KA</pubmed_authors><pubmed_authors>Lambert SR</pubmed_authors><pubmed_authors>Bremer D</pubmed_authors><pubmed_authors>Ghasia F</pubmed_authors><pubmed_authors>Friedman I</pubmed_authors><pubmed_authors>Galvin J</pubmed_authors><pubmed_authors>Freedman SF</pubmed_authors><pubmed_authors>Dittman E</pubmed_authors><pubmed_authors>Karr DJ</pubmed_authors><pubmed_authors>Young MP</pubmed_authors><pubmed_authors>Gallerson BK</pubmed_authors><pubmed_authors>Cassady C</pubmed_authors><pubmed_authors>Mohney BG</pubmed_authors><pubmed_authors>Baird AM</pubmed_authors><pubmed_authors>Kaplon JD</pubmed_authors><pubmed_authors>Rogers D</pubmed_authors><pubmed_authors>Hutchinson AK</pubmed_authors><pubmed_authors>Boyle NM</pubmed_authors><pubmed_authors>Morrison DG</pubmed_authors><pubmed_authors>Saunders RA</pubmed_authors><pubmed_authors>Grigorian AP</pubmed_authors><pubmed_authors>Smith H</pubmed_authors><pubmed_authors>Plager DA</pubmed_authors><pubmed_authors>Smith J</pubmed_authors><pubmed_authors>Fallaha N</pubmed_authors><pubmed_authors>Ghadban R</pubmed_authors><pubmed_authors>Bowman CS</pubmed_authors><pubmed_authors>Rauch PK</pubmed_authors><pubmed_authors>Neilsen RA</pubmed_authors><pubmed_authors>Czubinski A</pubmed_authors><pubmed_authors>Kumar K</pubmed_authors><pubmed_authors>Shah B</pubmed_authors><pubmed_authors>Cupit S</pubmed_authors><pubmed_authors>Govreau D</pubmed_authors><pubmed_authors>Hamel P</pubmed_authors><pubmed_authors>Nye C</pubmed_authors><pubmed_authors>Crouch ER</pubmed_authors><pubmed_authors>Chandler DL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Incidence of Glaucoma-Related Adverse Events in the First 5 Years After Pediatric Lensectomy.</name><description>&lt;h4>Importance&lt;/h4>Glaucoma can develop following cataract removal in children.&lt;h4>Objective&lt;/h4>To assess the cumulative incidence of glaucoma-related adverse events (defined as glaucoma or glaucoma suspect) and factors associated with risk of these adverse events in the first 5 years after lensectomy prior to 13 years of age.&lt;h4>Design, setting, and participants&lt;/h4>This cohort study used longitudinal registry data collected at enrollment and annually for 5 years from 45 institutional and 16 community sites. Participants were children aged 12 years or younger with at least 1 office visit after lensectomy from June 2012 to July 2015. Data were analyzed from February through December 2022.&lt;h4>Exposures&lt;/h4>Usual clinical care after lensectomy.&lt;h4>Main outcomes and measures&lt;/h4>The main outcomes were cumulative incidence of glaucoma-related adverse events and baseline factors associated with risk of these adverse events.&lt;h4>Results&lt;/h4>The study included 810 children (1049 eyes); 443 eyes of 321 children (55% female; mean [SD] age, 0.89 [1.97] years) were aphakic after lensectomy, and 606 eyes of 489 children (53% male; mean [SD] age, 5.65 [3.32] years) were pseudophakic. The 5-year cumulative incidence of glaucoma-related adverse events was 29% (95% CI, 25%-34%) in 443 eyes with aphakia and 7% (95% CI, 5%-9%) in 606 eyes with pseudophakia; 7% (95% CI, 5%-10%) of aphakic eyes and 3% (95% CI, 2%-5%) of pseudophakic eyes were diagnosed as glaucoma suspect. Among aphakic eyes, a higher risk for glaucoma-related adverse events was associated with 4 of 8 factors, including age less than 3 months (vs ≥3 months: adjusted hazard ratio [aHR], 2.88; 99% CI, 1.57-5.23), abnormal anterior segment (vs normal: aHR, 2.88; 99% CI, 1.56-5.30), intraoperative complications at time of lensectomy (vs none; aHR, 2.25; 99% CI, 1.04-4.87), and bilaterality (vs unilaterality: aHR, 1.88; 99% CI, 1.02-3.48). Neither of the 2 factors evaluated for pseudophakic eyes, laterality and anterior vitrectomy, were associated with risk of glaucoma-related adverse events.&lt;h4>Conclusions and relevance&lt;/h4>In this cohort study, glaucoma-related adverse events were common after cataract surgery in children; age less than 3 months at surgery was associated with elevated risk of the adverse events in aphakic eyes. Children with pseudophakia, who were older at surgery, less frequently developed a glaucoma-related adverse event within 5 years of lensectomy. The findings suggest that ongoing monitoring for the development of glaucoma is needed after lensectomy at any age.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2026-06-14T05:36:04.893Z</modification><creation>2025-04-06T03:56:15.779Z</creation></dates><accession>S-EPMC9936384</accession><cross_references><pubmed>36795393</pubmed><doi>10.1001/jamaophthalmol.2022.6413</doi></cross_references></HashMap>